DENTSPLY SIRONA director receives 28,887-share RSU grant

DENTSPLY SIRONA Inc. director James D. Forbes reported an acquisition of 28,887 shares of common stock through an equity grant.

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director James D. Forbes reported an acquisition of 28,887 shares of common stock through an equity grant. The grant was made at no cash cost per share and reflects a compensation-related award rather than an open-market purchase.

The award consists entirely of Restricted Stock Units that vest in full one year from the grant date, meaning restrictions lapse at that time if conditions are met. Following this grant, Forbes directly holds a total of 38,887 shares of DENTSPLY SIRONA common stock.

Insider Trade Summary

Grant/Award: 28,887 shares

Grant/Award 1 txn

Insider Forbes James D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,887	$0.00	$0.00

Holdings After Transaction: Common Stock — 38,887 shares (Direct)

Footnotes (1)

1. F1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Key Figures

RSU grant size: 28,887 shares Grant price: $0.00 per share Shares after grant: 38,887 shares +1 more

4 metrics

RSU grant size 28,887 shares Restricted Stock Units awarded to James D. Forbes

Grant price $0.00 per share Equity award, not open-market purchase

Shares after grant 38,887 shares Total direct holdings following the transaction

Vesting period One year RSUs vest in full one year from grant date

Key Terms

Restricted Stock Units (RSUs), Grant, award, or other acquisition, Common Stock, Form 4

4 terms

Restricted Stock Units (RSUs) financial

"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DENTSPLY SIRONA (XRAY) director James D. Forbes report?

James D. Forbes reported receiving 28,887 shares of DENTSPLY SIRONA common stock as an equity grant. The transaction was coded as an acquisition award and did not involve an open-market purchase, reflecting compensation rather than a discretionary buy in the market.

Are the 28,887 DENTSPLY SIRONA (XRAY) shares a grant or an open-market purchase?

The 28,887 shares are a grant, not an open-market purchase. They were awarded at a price of $0.00 per share under a compensation plan, classified as a grant or award acquisition rather than a buy transaction on the public market.

How many DENTSPLY SIRONA (XRAY) shares does James D. Forbes hold after this Form 4?

After the reported grant, James D. Forbes holds 38,887 shares of DENTSPLY SIRONA common stock directly. This total includes the newly granted 28,887 shares, increasing his reported direct ownership position as disclosed in the Form 4 filing.

What are the vesting terms of the DENTSPLY SIRONA (XRAY) RSU grant to James D. Forbes?

The grant consists entirely of Restricted Stock Units that vest in full one year from the grant date. Until vesting, the units are subject to restrictions, which lapse after that one-year period if the applicable conditions are satisfied.

Does the DENTSPLY SIRONA (XRAY) Form 4 indicate any derivative securities for James D. Forbes?

The Form 4 indicates no derivative securities for James D. Forbes in this filing. The reported transaction involves only non-derivative common stock received via a Restricted Stock Unit grant, with no remaining derivative positions listed in the derivative summary section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forbes James D

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NORTH CAROLINA 28277

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		28,887(1)	A	$0	38,887	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for James D. Forbes	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)